These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7657075)

  • 21. Haemodynamic aspects and serotonin.
    Dabiré H; Cherqui C; Safar M; Schmitt H
    Clin Physiol Biochem; 1990; 8 Suppl 3():56-63. PubMed ID: 2132176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological relevance of serotonin.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S19-25. PubMed ID: 2446063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin 5-HT2 receptors and brain circulation.
    Wiernsperger N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S20-4. PubMed ID: 1369712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptors involved in the 5-hydroxytryptamine-induced contraction of isolated cerebral arteries.
    Young AR; MacKenzie ET; Seylaz J; Verrecchia C
    Acta Physiol Scand Suppl; 1986; 552():54-7. PubMed ID: 3468750
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
    Lüscher TF; Tanner FC; Bühler FR
    Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
    [No Abstract]   [Full Text] [Related]  

  • 27. 5-hydroxytryptamine and cardiovascular regulation.
    Ramage AG; Villalón CM
    Trends Pharmacol Sci; 2008 Sep; 29(9):472-81. PubMed ID: 19086344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review.
    De Clerck F; van Nueten JM; Reneman RS
    Agents Actions; 1984 Dec; 15(5-6):612-26. PubMed ID: 6397984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-hydroxytryptamine and vascular disease.
    Vanhoutte PM
    Fed Proc; 1983 Feb; 42(2):233-7. PubMed ID: 6822294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serotonin and cardiovascular control].
    Aurup P; Højberg S
    Ugeskr Laeger; 1990 Sep; 152(39):2840-3. PubMed ID: 2219514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of serotonin in the regulation of the circulatory system].
    Buczko W
    Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation.
    Doggrell SA
    Expert Opin Investig Drugs; 2003 May; 12(5):805-23. PubMed ID: 12720492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS; Vanhoutte PM
    Drugs; 1986 Feb; 31(2):149-63. PubMed ID: 3512233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):69S-74S. PubMed ID: 2268509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT: the promiscuous and happy hormone!
    Barnes NM
    Curr Opin Pharmacol; 2011 Feb; 11(1):1-2. PubMed ID: 21420360
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical application of serotonin antagonists in the treatment of hypertension].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
    Frishman WH; Huberfeld S; Okin S; Wang YH; Kumar A; Shareef B
    J Clin Pharmacol; 1995 Jun; 35(6):541-72. PubMed ID: 7665716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.
    Peroutka SJ
    Biochem Pharmacol; 1984 Aug; 33(15):2349-53. PubMed ID: 6380502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.